Investor Relations > Profile
Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) was founded in 1982 and became a publicly traded company in 1992. Hi-Tech is a specialty pharmaceuticals manufacturer and marketer of generic prescription and branded OTC products for the general healthcare industry.
The Company specializes in difficult-to-manufacture liquid and semi-solid dosage forms and manufactures a range of sterile ophthalmic, otic and inhalation products.
The Company's Health Care Products Division (HCP) is widely viewed as the leader of over the counter and nutritional products targeted to the diabetic consumer. Its Diabetic Tussin(r) line of products has consistently ranked as number one among sugar free cough and cold medications.
Hi-Tech's strategy is to become a leader in liquid and semi-solid generic drug development, manufacturing and distribution. To achieve that, the Company has been consistently investing in its manufacturing infrastructure and building its pipeline of products, through internal R&D effort, partnerships and licensing activities.